<DOC>
	<DOCNO>NCT01328964</DOCNO>
	<brief_summary>The objective study compare asthma-related exacerbation ( emergency department ( ED ) inpatient ( IP ) visit ) relate cost pediatric patient age 4-11 year receive either fluticasone propionate 44 mcg ( FP44 ) budesonide ( BUD ) montelukast ( MON ) . This retrospective observational cohort analysis utilizes large manage care database link pharmacy medical claim . Patients ≥ 1 pharmacy claim FP44 BUD MON January 1 , 2000 June 30 , 2008 ( 4-11 year old time index ) ≥ 1 diagnosis asthma ( ICD-9 493.xx ) pre-index period continuously eligible receive healthcare service 1-year pre-index least 30 day post-index . Dose inhaled corticosteroid know database . Follow-up define patient period begin index date end last date continuous claim history , switch another asthma controller medication , claim asthma relate event ( ED/IP visit OCS use ) post-index , whichever occur first .</brief_summary>
	<brief_title>Comparison Asthma-related Outcomes Costs Pediatric Subjects That Received Fluticasone Propionate , Budesonide Montelukast Large Managed Care Population</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>ICD9 code asthma one outpatient pharmacy claim fluticasone propionate 44mg budesonide January 1 , 2000 June 30 , 2008 age 4 11 year diagnosis Cystic Fibrosis ≥ 1 Rx claim asthma controller preindex period</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>pediatric</keyword>
	<keyword>asthma</keyword>
	<keyword>outcome</keyword>
	<keyword>inhaled cortcosteroids</keyword>
</DOC>